tiprankstipranks
Trending News
More News >
Scholar Rock Holding Corp (SRRK)
NASDAQ:SRRK
US Market

Scholar Rock Holding (SRRK) Stock Forecast & Price Target

Compare
528 Followers
See the Price Targets and Ratings of:

SRRK Analyst Ratings

Strong Buy
12Ratings
Strong Buy
12 Buy
0 Hold
0 Sell
Based on 12 analysts giving stock ratings to
Scholar
Rock Holding
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SRRK Stock 12 Month Forecast

Average Price Target

$50.30
▲(14.97% Upside)
Based on 12 Wall Street analysts offering 12 month price targets for Scholar Rock Holding in the last 3 months. The average price target is $50.30 with a high forecast of $60.00 and a low forecast of $42.00. The average price target represents a 14.97% change from the last price of $43.75.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"28":"$28","61":"$61","36.25":"$36.3","44.5":"$44.5","52.75":"$52.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":60,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$60.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":50.3,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$50.30</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":42,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$42.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[28,36.25,44.5,52.75,61],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2025","6":"Jul<br/>2025","9":"Oct<br/>2025","12":"Jan<br/>2026","25":"Jan<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,44.05,45.276923076923076,46.503846153846155,47.730769230769226,48.957692307692305,50.184615384615384,51.41153846153846,52.63846153846154,53.86538461538461,55.09230769230769,56.31923076923077,57.54615384615384,58.77307692307693,{"y":60,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,44.05,44.53076923076923,45.01153846153846,45.49230769230769,45.97307692307692,46.45384615384615,46.934615384615384,47.41538461538461,47.896153846153844,48.37692307692308,48.857692307692304,49.33846153846154,49.819230769230764,{"y":50.3,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,44.05,43.89230769230769,43.73461538461538,43.57692307692307,43.419230769230765,43.26153846153846,43.10384615384615,42.94615384615385,42.78846153846154,42.63076923076923,42.473076923076924,42.315384615384616,42.15769230769231,{"y":42,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":43.22,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":40.38,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.82,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.06,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32.76,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.76,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":33.76,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":36.36,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":33.12,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.68,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.62,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.99,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.05,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$60.00Average Price Target$50.30Lowest Price Target$42.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Raymond James Analyst forecast on SRRK
Raymond James
Raymond James
$40.86$53
Buy
21.14%
Upside
Reiterated
01/13/26
Raymond James Keeps Their Buy Rating on Scholar Rock Holding (SRRK)
Bank of America Securities Analyst forecast on SRRK
Bank of America Securities
Bank of America Securities
$49$50
Buy
14.29%
Upside
Reiterated
01/13/26
Scholar Rock price target raised to $50 from $49 at BofAScholar Rock price target raised to $50 from $49 at BofA
Wedbush Analyst forecast on SRRK
Unknown Analyst
Wedbush
Not Ranked
Wedbush
$50
Buy
14.29%
Upside
Reiterated
01/13/26
Wedbush Remains a Buy on Scholar Rock Holding (SRRK)
TD Cowen Analyst forecast on SRRK
TD Cowen
TD Cowen
Buy
Reiterated
01/12/26
We continue to view the approval as a matter of when, not if, and remain at Buy for the eventual SMA launch.
BMO Capital Analyst forecast on SRRK
BMO Capital
BMO Capital
$50
Buy
14.29%
Upside
Reiterated
01/12/26
Scholar Rock: Apitegromab Manufacturing Resolution and Pipeline Expansion Underpin Buy-Rated Risk-Reward Profile
Citi
$55
Buy
25.71%
Upside
Initiated
01/09/26
Buy/High Risk: Apitegromab’s Differentiated SMA Profile and Expanding Neuromuscular Upside Support Significant Re-Rating Potential
UBS
$60
Buy
37.14%
Upside
Initiated
01/07/26
Scholar Rock initiated with a Buy at UBSScholar Rock initiated with a Buy at UBS
Barclays Analyst forecast on SRRK
Barclays
Barclays
$45$52
Buy
18.86%
Upside
Reiterated
12/17/25
Scholar Rock Holding (SRRK) Receives a Buy from Barclays
Truist Financial Analyst forecast on SRRK
Truist Financial
Truist Financial
Buy
Reiterated
12/15/25
Analysts Offer Insights on Healthcare Companies: Novan (NASDAQ: NOVN), Pelthos Therapeutics (NYSE MKT: PTHS) and Scholar Rock Holding (NASDAQ: SRRK)
J.P. Morgan Analyst forecast on SRRK
J.P. Morgan
J.P. Morgan
$46$47
Buy
7.43%
Upside
Reiterated
11/18/25
Scholar Rock price target raised to $47 from $46 at JPMorganScholar Rock price target raised to $47 from $46 at JPMorgan
H.C. Wainwright Analyst forecast on SRRK
H.C. Wainwright
H.C. Wainwright
$44
Buy
0.57%
Upside
Reiterated
11/17/25
Scholar Rock Holding's Promising Future: Buy Rating Affirmed Amid Strategic Advancements and Market Positioning
Wolfe Research Analyst forecast on SRRK
Unknown Analyst
Wolfe Research
Not Ranked
Wolfe Research
$42
Buy
-4.00%
Downside
Initiated
11/17/25
Scholar Rock initiated with an Outperform at Wolfe ResearchScholar Rock initiated with an Outperform at Wolfe Research
Piper Sandler Analyst forecast on SRRK
Piper Sandler
Piper Sandler
$51
Buy
16.57%
Upside
Reiterated
10/14/25
Piper Sandler Keeps Their Buy Rating on Scholar Rock Holding (SRRK)
Leerink Partners Analyst forecast on SRRK
Leerink Partners
Leerink Partners
$51$48
Buy
9.71%
Upside
Reiterated
09/25/25
Leerink Partners Reaffirms Their Buy Rating on Scholar Rock Holding (SRRK)
Roth MKM Analyst forecast on SRRK
Unknown Analyst
Roth MKM
Not Ranked
Roth MKM
$45
Buy
2.86%
Upside
Initiated
09/17/25
Scholar Rock Holding (SRRK) Receives a New Rating from Roth MKM
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Raymond James Analyst forecast on SRRK
Raymond James
Raymond James
$40.86$53
Buy
21.14%
Upside
Reiterated
01/13/26
Raymond James Keeps Their Buy Rating on Scholar Rock Holding (SRRK)
Bank of America Securities Analyst forecast on SRRK
Bank of America Securities
Bank of America Securities
$49$50
Buy
14.29%
Upside
Reiterated
01/13/26
Scholar Rock price target raised to $50 from $49 at BofAScholar Rock price target raised to $50 from $49 at BofA
Wedbush Analyst forecast on SRRK
Unknown Analyst
Wedbush
Not Ranked
Wedbush
$50
Buy
14.29%
Upside
Reiterated
01/13/26
Wedbush Remains a Buy on Scholar Rock Holding (SRRK)
TD Cowen Analyst forecast on SRRK
TD Cowen
TD Cowen
Buy
Reiterated
01/12/26
We continue to view the approval as a matter of when, not if, and remain at Buy for the eventual SMA launch.
BMO Capital Analyst forecast on SRRK
BMO Capital
BMO Capital
$50
Buy
14.29%
Upside
Reiterated
01/12/26
Scholar Rock: Apitegromab Manufacturing Resolution and Pipeline Expansion Underpin Buy-Rated Risk-Reward Profile
Citi
$55
Buy
25.71%
Upside
Initiated
01/09/26
Buy/High Risk: Apitegromab’s Differentiated SMA Profile and Expanding Neuromuscular Upside Support Significant Re-Rating Potential
UBS
$60
Buy
37.14%
Upside
Initiated
01/07/26
Scholar Rock initiated with a Buy at UBSScholar Rock initiated with a Buy at UBS
Barclays Analyst forecast on SRRK
Barclays
Barclays
$45$52
Buy
18.86%
Upside
Reiterated
12/17/25
Scholar Rock Holding (SRRK) Receives a Buy from Barclays
Truist Financial Analyst forecast on SRRK
Truist Financial
Truist Financial
Buy
Reiterated
12/15/25
Analysts Offer Insights on Healthcare Companies: Novan (NASDAQ: NOVN), Pelthos Therapeutics (NYSE MKT: PTHS) and Scholar Rock Holding (NASDAQ: SRRK)
J.P. Morgan Analyst forecast on SRRK
J.P. Morgan
J.P. Morgan
$46$47
Buy
7.43%
Upside
Reiterated
11/18/25
Scholar Rock price target raised to $47 from $46 at JPMorganScholar Rock price target raised to $47 from $46 at JPMorgan
H.C. Wainwright Analyst forecast on SRRK
H.C. Wainwright
H.C. Wainwright
$44
Buy
0.57%
Upside
Reiterated
11/17/25
Scholar Rock Holding's Promising Future: Buy Rating Affirmed Amid Strategic Advancements and Market Positioning
Wolfe Research Analyst forecast on SRRK
Unknown Analyst
Wolfe Research
Not Ranked
Wolfe Research
$42
Buy
-4.00%
Downside
Initiated
11/17/25
Scholar Rock initiated with an Outperform at Wolfe ResearchScholar Rock initiated with an Outperform at Wolfe Research
Piper Sandler Analyst forecast on SRRK
Piper Sandler
Piper Sandler
$51
Buy
16.57%
Upside
Reiterated
10/14/25
Piper Sandler Keeps Their Buy Rating on Scholar Rock Holding (SRRK)
Leerink Partners Analyst forecast on SRRK
Leerink Partners
Leerink Partners
$51$48
Buy
9.71%
Upside
Reiterated
09/25/25
Leerink Partners Reaffirms Their Buy Rating on Scholar Rock Holding (SRRK)
Roth MKM Analyst forecast on SRRK
Unknown Analyst
Roth MKM
Not Ranked
Roth MKM
$45
Buy
2.86%
Upside
Initiated
09/17/25
Scholar Rock Holding (SRRK) Receives a New Rating from Roth MKM
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Scholar Rock Holding

3 Months
xxx
Success Rate
7/10 ratings generated profit
70%
Average Return
+52.10%
reiterated a xxx
rating 30 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 70.00% of your transactions generating a profit, with an average return of +52.10% per trade.
1 Year
Allison BratzelPiper Sandler
Success Rate
12/12 ratings generated profit
100%
Average Return
+106.70%
reiterated a buy rating 3 months ago
Copying Allison Bratzel's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +106.70% per trade.
2 Years
xxx
Success Rate
12/12 ratings generated profit
100%
Average Return
+191.96%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +191.96% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SRRK Analyst Recommendation Trends

Rating
Sep 25
Oct 25
Nov 25
Dec 25
Jan 26
Strong Buy
3
7
6
4
0
Buy
19
21
23
16
18
Hold
0
0
0
1
6
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
22
28
29
21
24
In the current month, SRRK has received 18 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. SRRK average Analyst price target in the past 3 months is 50.30.
Each month's total comprises the sum of three months' worth of ratings.

SRRK Financial Forecast

SRRK Earnings Forecast

Next quarter’s earnings estimate for SRRK is -$0.90 with a range of -$1.06 to -$0.70. The previous quarter’s EPS was -$0.90. SRRK beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year SRRK has Performed in-line its overall industry.
Next quarter’s earnings estimate for SRRK is -$0.90 with a range of -$1.06 to -$0.70. The previous quarter’s EPS was -$0.90. SRRK beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year SRRK has Performed in-line its overall industry.

SRRK Sales Forecast

Next quarter’s sales forecast for SRRK is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. SRRK beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year SRRK has Performed in-line its overall industry.
Next quarter’s sales forecast for SRRK is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. SRRK beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year SRRK has Performed in-line its overall industry.

SRRK Stock Forecast FAQ

What is SRRK’s average 12-month price target, according to analysts?
Based on analyst ratings, Scholar Rock Holding Corp’s 12-month average price target is 50.30.
    What is SRRK’s upside potential, based on the analysts’ average price target?
    Scholar Rock Holding Corp has 14.97% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is SRRK a Buy, Sell or Hold?
          Scholar Rock Holding Corp has a consensus rating of Strong Buy which is based on 12 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Scholar Rock Holding Corp’s price target?
            The average price target for Scholar Rock Holding Corp is 50.30. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $60.00 ,the lowest forecast is $42.00. The average price target represents 14.97% Increase from the current price of $43.75.
              What do analysts say about Scholar Rock Holding Corp?
              Scholar Rock Holding Corp’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.
                How can I buy shares of SRRK?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.